메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Role of CathWorks FFRangio for the Assessment of Coronary Artery Disease Now Reinforced by SCAI Expert Opinion

NEWPORT BEACH, Calif., Feb. 4, 2026 -- CathWorks, a global leader in digital health innovations, announced that the Society for Cardiovascular Angiography & Interventions (SCAI) published an expert opinion discussing the expanding role of angiography-derived physiology (ADP), a wire-free method for coronary physiologic assessment. By applying different principles, in some cases in conjunction with artificial intelligence (AI), ADP provides physiologic insights from routine angiograms, representing a paradigm shift in the catheterization lab. The expert opinion focused on th
- 김갑성 기자
- 2026-02-04 02:05
United Imaging Healthcare North America Welcomes John Campbell as Vice President of Customer Success

HOUSTON, Feb. 4, 2026 -- United Imaging, a global leader in advanced medical imaging and radiotherapy solutions, is pleased to announce that John Campbell recently joined the organization as Vice President of Customer Success, North America. In this role, he will support United Imaging's continued growth by strengthening customer partnerships, advancing service excellence, and ensuring long-term value delivery across the installed base. John brings more than 25 years of experience in the healthcare and medical imaging industry, with a career spanning military service, field operations,
- 김갑성 기자
- 2026-02-04 01:00
Metabolon Names Andrew Messick Chief Financial Officer

Seasoned life sciences finance leader brings deep expertise in operational excellence and M&A to support Metabolon's next stage of growth MORRISVILLE, N.C., Feb. 3, 2026 -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announces the appointment of Andrew (Drew) Messick as Chief Financial Officer. "Drew brings more than 25 years of financial leadership experience, with a proven track record of driving growth through
- 김갑성 기자
- 2026-02-03 22:00
Akso Health Group Announces Launch of Exploratory Global Patient Support Initiative

QINGDAO, China, Feb. 3, 2026 -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the launch of the an exploratory patient support program and a strategic cooperation with Nanning Duoling Research Institute. Adopting an integrated model of "Traditional Chinese Medicine (TCM) practice + modern medical technology", certain medical resources will be coordinated and integrated to provide free in-hospital treatment plans for up to 10,000 eligible patients within participating medical institutions. The patient support program directly add
- 황정호 기자
- 2026-02-03 22:00
Insilico Medicine Receives USD 5million Milestone Payment from Menarini Group Following First-in-Human (FIH) Achievement for MEN2501

[ 메디채널 김갑성 기자 ] Followed by the development and regulatory milestone payment of USD 3 million in July 2025, Insilico received an additional milestone payment of USD 5 million from Menarini Group after first-in-patient dosing in a Phase 1 trial of MEN2501, highly differentiated small molecule KIF18A inhibitor in development for chromosomally unstable solid tumors designed using Insilico's generative AI engine. CAMBRIDGE, Mass., Feb. 3, 2026 -- Insilico Medicine ("Insilico"), a clinical-stage, generative artificial intelligence (AI)-driven biotechnology company, today announc
- 김갑성 기자
- 2026-02-03 22:00
NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer

NEW YORK, Feb. 3, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer Ashley Mastronardi delivers the pre-market update on February 3rd Stocks are mixed as investors track a heavy week of corporate earnings — including reports from NYSE‑listed Pfizer, Eaton, Uber, and Eli Lilly — while labor data is disrupted by
- 황정호 기자
- 2026-02-03 21:58
Ispire Technology Inc.、2026年度第2四半期決算電話会議の開催を予定

ロサンゼルス, 2026年2月3日 -- 電子タバコ技術と精密投与の先駆者であるIspire Technology Inc.（以下「Ispire」または「当社」）（NASDAQ：ISPR）は本日、2025年12月31日に終了した第2四半期の決算結果について説明するため、2026年2月6日（金曜）午前8時（米国東部時間）より決算電話会議を開催することを発表しました。決算説明会をお聞きになるには、以下の情報を使用してお電話でご参加ください。電話接続時に案内があった際は、「Ispire Technology Call」とお申し出ください。開催日：2026年2月6日（金曜）時間：午前8時（米国東部時間）ダイヤル・イン番号：米国からは877-451-6152、海外からは+1 201-389-0879におかけください。この電話会議はウェブキャストでライブ配信され、関係者全員が以下からアクセスできます：https://viavid.webcasts.com/starthere.jsp?ei=1749224&tp_key=1ec45fe266 通話開始の少なくとも15分前までにリンクにアクセスして登録の上、必要なオーディオ・ソフトウェアのダウンロードおよびインストールを行なってください。&
- 김갑성 기자
- 2026-02-03 21:25
BioDlink Modernizes Quality Management with Successful Go-Live of Veeva QMS

BioDlink has successfully implemented Veeva QMS, marking a key milestone in its digital transformation and strengthening its GMP quality management capabilities. It enables a standardized, data-driven quality framework, supporting compliance, efficiency, and long-term continuous improvement for global partners. SUZHOU, China, Feb. 3, 2026 -- BioDlink today announced the successful go-live of Veeva QMS, marking a key milestone in the company's quality digitalization strategy. The system officially entered operation following a launch event held on January 29 with represen
- 김갑성 기자
- 2026-02-03 21:00
True Terpenes Launches Headstash™: A Breakthrough in Compliant Cannabis Aroma Science

Restores & revives plant's most elusive aromatic compounds—at scale & across all supply chains PORTLAND, Ore., Feb. 3, 2026 -- True Terpenes, a global leader in terpene science and aroma innovation serving 107 countries and powering over $8 billion in global CPG annually, today announced the launch of Headstash™, a first-of-its-kind aromatic product engineered to deliver the most authentic expression of cannabis aroma while meeting the strictest compliance standards. Designed to preserve and reconstruct the plant's most aromatic volatile compounds, Headstash sets a new
- 김갑성 기자
- 2026-02-03 21:00
CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access

OSLO, Norway and INCHEON, South Korea, Feb. 3, 2026 -- The Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced a partnership to strengthen vaccine manufacturing preparedness for future epidemic and pandemic threats. The collaboration will see Samsung Biologics join CEPI's Vaccine Manufacturing Facility Network (VMFN) with the aim of accelerating the availability of protein-based vaccines and advancing equitable access to those vaccines during future outbreaks in Low
- 김갑성 기자
- 2026-02-03 21:00

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 03일 01시 00분